AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANTX AN2 Therapeutics, Inc.

休市中 11-15 16:00:00 EST

1.00

+0.00

0.00%

盘后1.00

+0.000.00%

18:27 EST

最高1.04	最低0.9945	成交量124.74万
今开1.00	昨收1.00	日振幅4.55%
总市值2,984万	流通市值1,138万	总股本2,984万
成交额125.05万	换手率10.96%	流通股本1,138万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":1,"timestamp":1731704400000,"preClose":1,"halted":0,"volume":1247439,"hourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"18:27 EST","volume":2,"amount":1.98,"timestamp":1731713261804},"delay":0,"floatShares":11380500,"shares":29842431,"eps":-2.246899,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"11-15 16:00:00 EST","open":1,"high":1.04,"low":0.9945,"amount":1250489.7368184,"amplitude":0.0455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.246899,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1648180800000,"adjPreClose":1,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.01,"preClose":1,"latestTime":"09:28 EST","volume":5100,"amount":5200.50009,"timestamp":1731680908138},"postHourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"18:27 EST","volume":2,"amount":1.98,"timestamp":1731713261804},"volumeRatio":1.396188660513788},"requestUrl":"/m/hq/s/ANTX/wiki","defaultTab":"wiki","newsList":[{"id":"2477886375","title":"An2 Therapeutics, Inc.盘中异动 早盘股价大涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477886375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477886375?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517659,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分，An2 Therapeutics, Inc.股票出现波动，股价快速拉升5.71%。截至发稿，该股报1.11美元/股，成交量11.0649万股，换手率0.37%，振幅3.75%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213419a1e24972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213419a1e24972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2460587020","title":"An2 Therapeutics, Inc.盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460587020","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460587020?lang=zh_cn&edition=full","pubTime":"2024-08-19 22:54","pubTimestamp":1724079248,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日22时54分，An2 Therapeutics, Inc.股票出现波动，股价大幅拉升5.10%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192254089719929d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192254089719929d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ANTX","LENZ"],"gpt_icon":0},{"id":"2460249225","title":"An2 Therapeutics, Inc.2024财年第二财季实现净利润-14.44百万美元，同比增加8.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249225","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249225?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824040,"startTime":"0","endTime":"0","summary":"8月17日，An2 Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-14.44百万美元，同比增加8.61%；其中营业收入为0.00美元，每股基本收益为-0.48美元。机构评级：截至2024年8月17日，当前有3家机构对An2 Therapeutics, Inc.目标价做出预测，其中目标均价为2.00美元，其中最低目标价为1.00美元，最高目标价为3.00美元。公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000635959f2dbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000635959f2dbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","LENZ"],"gpt_icon":0},{"id":"2459170559","title":"An2 Therapeutics, Inc.盘中异动 早盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459170559","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459170559?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:03","pubTimestamp":1723644190,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时03分，An2 Therapeutics, Inc.股票出现异动，股价急速下跌5.50%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422031098e34eff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081422031098e34eff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2459909496","title":"An2 Therapeutics, Inc.盘中异动 大幅上涨6.80%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459909496","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459909496?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:30","pubTimestamp":1723555856,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时30分，An2 Therapeutics, Inc.股票出现波动，股价快速上涨6.80%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321305797198a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321305797198a5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ANTX","BK4007"],"gpt_icon":0},{"id":"2458829513","title":"BUZZ--美国股票走势-Synchrony、Grindr、Blend Labs","url":"https://stock-news.laohu8.com/highlight/detail?id=2458829513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458829513?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:54","pubTimestamp":1723218867,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月9日 - 华尔街主要股指周五将出现周度跌幅，为全球市场因低收益日圆大幅升值和对全球最大经济体经济衰退的担忧而陷入动荡的一周画上句号。美东时间11:47，道琼斯工业平均指数  上涨0.07%，报39,472.26点。标普500指数  上涨0.21%，报5330.55点；纳斯达克综合指数  上涨0.10%，报16677.113点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOG",".DJI","DJX","BLND","NTRA","LEGN","AXL","BK4554","LU1861220033.SGD","SOFI","IOVA","PODD","LU1861215975.USD","GRND.WS","QID","PBI","PGY","EXPE","SDOW","BK4533","SOLV","SYF","TTWO","ANTX","AKAM",".SPX","AMRX","QLD","GRND","MNQmain","UDOW","DOCS","BFH","DDM","HRTG","AIRS","DXD","NQmain","PSQ","SQQQ","NKLA","BUZZ","NFE",".IXIC","TQQQ","CUBI"],"gpt_icon":1},{"id":"2458901405","title":"BUZZ-AN2 Therapeutics 因终止肺病试验而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2458901405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458901405?lang=zh_cn&edition=full","pubTime":"2024-08-09 23:25","pubTimestamp":1723217144,"startTime":"0","endTime":"0","summary":"    8月9日 - ** 药物开发商AN2 Therapeutics  股价下跌60.9%至1.06美元，创下该股2022年上市以来的最低价 ** 周四晚些时候，ANTX表示将停止对其实验性肺病药物表四硼酸的中期和晚期试验。** ANTX 将解雇约 50%的员工，预计在 2024 年底前基本完成。** 作为重组的一部分，公司首席医疗官Paul Eckburg将于8月30日离职。** 包括本交易日的走势在内，该股今年累计下跌 94.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007","BK4139","BUZZ","LENZ"],"gpt_icon":0},{"id":"2458459614","title":"An2 Therapeutics, Inc.股价重挫47.35% 市值跌1963.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458459614","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458459614?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210280,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分，An2 Therapeutics, Inc.股票出现异动，股价急速跳水47.35%。截至发稿，该股报1.39美元/股，成交量20.3167万股，换手率0.68%，振幅7.33%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131219f1dc129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408092131219f1dc129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ANTX","BK4007"],"gpt_icon":0},{"id":"2458329021","title":"An2 Therapeutics, Inc.盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458329021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458329021?lang=zh_cn&edition=full","pubTime":"2024-08-09 03:48","pubTimestamp":1723146485,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日03时48分，An2 Therapeutics, Inc.股票出现波动，股价急速拉升5.26%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为3.61%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Dermata Therapeutics Inc C/Wts 、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Aditxt, Inc.较为活跃，换手率分别为448.13%、308.29%、221.76%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Entero Therapeutics Inc.，振幅分别为146.06%、54.41%、48.56%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034805aefdf584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809034805aefdf584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ANTX"],"gpt_icon":0},{"id":"2453886063","title":"An2 Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453886063","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453886063?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:49","pubTimestamp":1721832580,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时49分，An2 Therapeutics, Inc.股票出现异动，股价急速下跌5.09%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7451.44%、1173.07%、615.87%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.79%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724224940941fa2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724224940941fa2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ANTX","LENZ"],"gpt_icon":0},{"id":"2452165635","title":"An2 Therapeutics, Inc.盘中异动 急速拉升5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452165635","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452165635?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:56","pubTimestamp":1721228207,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时56分，An2 Therapeutics, Inc.股票出现异动，股价快速上涨5.75%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2743.82%、1230.13%、265.80%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.，振幅分别为76.39%、43.75%、31.25%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225647941f7f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717225647941f7f03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2448439141","title":"Leerink Partners：上调AN2 Therapeutics(ANTX.US)评级，由大市一致调整至优于大市评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448439141","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448439141?lang=zh_cn&edition=full","pubTime":"2024-07-04 02:21","pubTimestamp":1720030879,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","ANTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2448886234","title":"An2 Therapeutics, Inc.盘中异动 早盘急速上涨7.75%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448886234","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448886234?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:30","pubTimestamp":1720013438,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时30分，An2 Therapeutics, Inc.股票出现异动，股价大幅上涨7.75%。截至发稿，该股报2.30美元/股，成交量5.6038万股，换手率0.19%，振幅0.00%。An2 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。An2 Therapeutics, Inc.公司简介：AN2 Therapeutics Inc是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的药物，这些疾病的需求未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213038aef7c9a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213038aef7c9a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ANTX","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.an2therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0909},{"period":"1month","weight":-0.0566},{"period":"3month","weight":0.0204},{"period":"6month","weight":-0.5595},{"period":"1year","weight":-0.9391},{"period":"ytd","weight":-0.9512}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AN2 Therapeutics, Inc.于2017年2月在特拉华州注册成立。他们是一家临床阶段的生物制药公司，开发治疗罕见、慢性和严重传染病的治疗方法。他们的核心技术方法基于将硼化学用于他们的药物研发计划。他们正在开发用于治疗NTM肺病的口服epetraborole，这是一种罕见的慢性进行性传染病，由称为分枝杆菌的细菌引起，可导致不可逆的肺损伤并可能致命。","exchange":"NASDAQ","name":"AN2 Therapeutics, Inc.","nameEN":"AN2 Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"AN2 Therapeutics, Inc.,ANTX,AN2 Therapeutics, Inc.股票,AN2 Therapeutics, Inc.股票老虎,AN2 Therapeutics, Inc.股票老虎国际,AN2 Therapeutics, Inc.行情,AN2 Therapeutics, Inc.股票行情,AN2 Therapeutics, Inc.股价,AN2 Therapeutics, Inc.股市,AN2 Therapeutics, Inc.股票价格,AN2 Therapeutics, Inc.股票交易,AN2 Therapeutics, Inc.股票购买,AN2 Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AN2 Therapeutics, Inc.(ANTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供AN2 Therapeutics, Inc.(ANTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}